SBC Medical Group Holdings Inc.
- SBC · Nasdaq
- Services-Offices & Clinics of Doctors of Medicine
- Irvine, CA
- 863 employees
- CIK 0001930313
Updated from SEC filings through
Top things to know
Executives
- Yoshiyuki Aikawa Chairman and CEO 4, 2026-04-29
- Ryoji Murata Principal Accounting Officer 10-K, 2026-03-27
SBC Medical Group Holdings Inc is a U.S. public company in services-offices & clinics of doctors of medicine (SIC 8011), headquartered in Irvine, CA. It trades as SBC on Nasdaq. Revenue was $174M in the fiscal year ending December 31, 2025, -15.5% from the year before. It reported about 863 employees. Yoshiyuki Aikawa is Chairman and CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $174M 10-K, 2026-03-27 | $205M 10-K, 2026-03-27 | $194M 10-K, 2025-03-28 |
| Operating income | $67.5M 10-K, 2026-03-27 | $70.3M 10-K, 2026-03-27 | $70.7M 10-K, 2025-03-28 |
| SG&A | $59.8M 10-K, 2026-03-27 | $57.7M 10-K, 2026-03-27 | $66.2M 10-K, 2025-03-28 |
| Net income | $51.0M 10-K, 2026-03-27 | $46.6M 10-K, 2026-03-27 | $39.4M 10-K, 2025-03-28 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Yoshiyuki Aikawa | Chairman and CEO | 4, 2026-04-29 |
| Yuya Yoshida | Director, Chief Financial Officer and Chief Operating Officer | 10-K, 2026-03-27 |
| Ryoji Murata | Principal Accounting Officer | 10-K, 2026-03-27 |
| Mike Sayama | independent director | 8-K, 2026-05-20 |
| Fumitoshi Fujiwara | Independent Director | 10-K, 2026-03-27 |
| Ken Edahiro | Independent Director | 10-K, 2026-03-27 |
What SBC Medical Group Holdings Inc does
,” referred to herein as “Pono,” as a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 102.8 million (as of July 31, 2026) | 10-Q, August 13, 2026 |
|---|---|---|
| Public float | $48.2M (as of June 30, 2025) | 10-K/A, April 30, 2026 |
| Reportable segments | 2 (period ending June 30, 2026) | 10-Q, August 13, 2026 |
| Latest proxy statement | Meeting May 28, 2026 (filed May 28, 2026) | DEF 14A, May 28, 2026 |
| Auditor | MaloneBailey, LLP (Tokyo, Japan) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| April 28, 2026 | Yoshiyuki Aikawa Chairman and CEO | Sale | 465,000 | $1.4M | Form 4, April 29, 2026 |
| April 21, 2026 | Yoshiyuki Aikawa Chairman and CEO | Sale | 3,100,000 | $9.4M | Form 4, April 23, 2026 |
| March 6, 2026 | Yoshiyuki Aikawa Chairman and CEO | Sale | 4,422,900 | $9.4M | Form 4, March 10, 2026 |
Recent 8-K events
- 8-K filed 2026-08-13
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-07-14
- Item 3.01 Notice of delisting or failure to meet listing standards
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-20
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-05-14
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-04-23
- Item 1.01 Entry into a material definitive agreement
- 8-K filed 2026-03-27
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
- 8-K filed 2026-01-05
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
- 8-K filed 2025-12-31
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
- 8-K filed 2025-12-15
- Item 8.01 Other events
- 8-K filed 2025-11-14
- Item 2.02 Results of operations and financial condition (earnings release)
Frequently asked questions about SBC Medical Group Holdings Inc
- What does SBC Medical Group Holdings Inc do?
- In its own words, from Item 1 of its 10-K: ",” referred to herein as “Pono,” as a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses."
- What is SBC Medical Group Holdings Inc's revenue?
- $174M for the fiscal year ending December 31, 2025, from its 10-K filed March 27, 2026.
- Is SBC Medical Group Holdings Inc profitable?
- SBC Medical Group Holdings Inc reported net income of $51.0M for the fiscal year ending December 31, 2025.
- How many employees does SBC Medical Group Holdings Inc have?
- About 863 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of SBC Medical Group Holdings Inc?
- Yoshiyuki Aikawa, Chairman and CEO, as named in a 4 filed April 29, 2026.
- Who is the CFO of SBC Medical Group Holdings Inc?
- Yuya Yoshida, Director, Chief Financial Officer and Chief Operating Officer, as named in a 10-K filed March 27, 2026.
- Where is SBC Medical Group Holdings Inc headquartered?
- Irvine, CA.
- What is SBC Medical Group Holdings Inc's stock ticker?
- SBC, SBCWW on Nasdaq.
- What industry is SBC Medical Group Holdings Inc in?
- Services-Offices & Clinics of Doctors of Medicine, SIC code 8011.
- What is SBC Medical Group Holdings Inc's website?
- sbc-holdings.com.
- When does SBC Medical Group Holdings Inc report earnings next?
- November 13, 2026 at 08:30. Source: ir_events.
- Is SBC Medical Group Holdings Inc a public company?
- Yes. SBC Medical Group Holdings Inc files with the SEC under CIK 0001930313 and trades as SBC.
- Who audits SBC Medical Group Holdings Inc?
- MaloneBailey, LLP, Tokyo, Japan, as named in its latest annual report (10-K).
- How many shares of SBC Medical Group Holdings Inc are outstanding?
- 102.8 million shares as of July 31, 2026, from its 10-Q filed August 13, 2026.
- What is SBC Medical Group Holdings Inc's public float?
- $48.2M as of June 30, 2025, as reported on the cover of its 10-K/A filed April 30, 2026.
- How many business segments does SBC Medical Group Holdings Inc report?
- 2 reportable segments for the period ending June 30, 2026, from its 10-Q filed August 13, 2026.
- When is SBC Medical Group Holdings Inc's annual shareholder meeting?
- May 28, 2026, per its proxy statement (DEF 14A) filed May 28, 2026.
- Have SBC Medical Group Holdings Inc insiders traded stock recently?
- Since March 6, 2026, officers and directors reported 3 open-market sales worth about $20.1M and 0 purchases on Forms 4 and 5. The most recent: Yoshiyuki Aikawa (Chairman and CEO) sold 465,000 shares on April 28, 2026.